Skip to content
10-Q

Quarterly Report

IMMUCELL CORP /DE/ ICCC

0001437749-26-017045

← back to feed
Filed
May 14, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 1, 2026 9.05M sh
Shares Diluted Q1 2026 · Mar 31, 2026 9.05M sh
Shares Diluted Q1 2026 · Mar 31, 2025 8.98M sh
Capex Q1 2026 · Mar 31, 2026 $177.23K
Capex Q1 2026 · Mar 31, 2025 $329.05K
Operating Cash Flow Q1 2026 · Mar 31, 2026 $3.57M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $1.57M
Long Term Debt Q1 2026 · Mar 31, 2026 $7.07M
Long Term Debt Q1 2026 · Dec 31, 2025 $7.49M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $6.81M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $3.81M
Stockholders Equity Q1 2026 · Mar 31, 2026 $29.14M
Stockholders Equity Q1 2026 · Dec 31, 2025 $27.06M
Stockholders Equity Q1 2026 · Mar 31, 2025 $28.99M
Stockholders Equity Q1 2026 · Dec 31, 2024 $27.52M
Current Liabilities Q1 2026 · Mar 31, 2026 $3.91M
Current Liabilities Q1 2026 · Dec 31, 2025 $3.98M
Total Liabilities Q1 2026 · Mar 31, 2026 $14.97M
Total Liabilities Q1 2026 · Dec 31, 2025 $15.48M
Current Assets Q1 2026 · Mar 31, 2026 $18.86M
Current Assets Q1 2026 · Dec 31, 2025 $16.94M
Total Assets Q1 2026 · Mar 31, 2026 $44.11M
Total Assets Q1 2026 · Dec 31, 2025 $42.53M
Total Assets Q1 2026 · Mar 31, 2025 $45.62M
Eps Diluted Q1 2026 · Mar 31, 2026 $0.21
Eps Diluted Q1 2026 · Mar 31, 2025 $0.16
Eps Basic Q1 2026 · Mar 31, 2026 $0.21
Eps Basic Q1 2026 · Mar 31, 2025 $0.16
Sga Expense Q1 2026 · Mar 31, 2026 $1.14M
Sga Expense Q1 2026 · Mar 31, 2025 $622.84K
Rd Expense Q1 2026 · Mar 31, 2026 $317.69K
Rd Expense Q1 2026 · Mar 31, 2025 $756.85K
Net Income Q1 2026 · Mar 31, 2026 $1.94M
Net Income Q1 2026 · Mar 31, 2025 $1.45M
Operating Income Q1 2026 · Mar 31, 2026 $1.97M
Operating Income Q1 2026 · Mar 31, 2025 $1.12M
Gross Profit Q1 2026 · Mar 31, 2026 $4.66M
Gross Profit Q1 2026 · Mar 31, 2025 $3.35M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $5.7M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $4.71M
Revenue Q1 2026 · Mar 31, 2026 $10.36M
Revenue Q1 2026 · Mar 31, 2025 $8.07M